1,030
Participants
Start Date
September 14, 2019
Primary Completion Date
June 27, 2024
Study Completion Date
July 6, 2024
Ondansetron Oral Solution
Six doses of oral ondansetron (0.15mg/kg) to be administered q8h (every 8 hours) to a maximum of 3 times in a 24 hour period, are provided to the participant/caregiver for use after emergency department disposition (i.e. home use), as needed.
Oral Placebo
Six doses of oral placebo (0.15mg/kg) to be administered q8h (every 8 hours) to a maximum of 3 times in a 24-hour period, are provided to the participant/caregiver for use after emergency department disposition (i.e. home use), as needed.
Alberta Children's Hospital, Calgary
Stollery Children's Hospital, Edmonton
Children's Hospital of Winnipeg, Winnipeg
Children's Hospital London Health Sciences Centre, London
Children's Hospital of Eastern Ontario (CHEO), Ottawa
Centre Hospitalier Universitaire Sainte Justine, Montreal
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
Women and Children's Health Research Institute (WCHRI)
UNKNOWN
The Hospital for Sick Children
OTHER
Children's Hospital Research Institute of Manitoba
OTHER
University of Manitoba
OTHER
Université de Montréal
OTHER
University of Ottawa
OTHER
University of Alberta
OTHER
Alberta Children's Hospital Research Institute
OTHER
Western University, Canada
OTHER
University of Calgary
OTHER